Steris PLC (NYSE:STE) Director Richard Martin Steeves sold 58,953 shares of Steris stock in a transaction dated Monday, March 5th. The shares were sold at an average price of $91.00, for a total transaction of $5,364,723.00. Following the completion of the sale, the director now directly owns 9,362 shares in the company, valued at approximately $851,942. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Steris PLC (NYSE STE) opened at $95.20 on Friday. The company has a quick ratio of 2.22, a current ratio of 2.82 and a debt-to-equity ratio of 0.46. Steris PLC has a 52 week low of $67.55 and a 52 week high of $95.41. The company has a market cap of $7,870.51, a PE ratio of 33.40 and a beta of 1.17.
Steris (NYSE:STE) last announced its quarterly earnings data on Wednesday, February 7th. The medical equipment provider reported $1.12 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.07 by $0.05. Steris had a net margin of 9.42% and a return on equity of 11.57%. The firm had revenue of $661.90 million during the quarter, compared to analysts’ expectations of $663.17 million. During the same quarter last year, the business earned $0.98 earnings per share. The business’s revenue for the quarter was up 2.3% compared to the same quarter last year. research analysts forecast that Steris PLC will post 4.13 EPS for the current fiscal year.
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Benjamin F. Edwards & Company Inc. lifted its stake in shares of Steris by 5.9% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 9,817 shares of the medical equipment provider’s stock valued at $859,000 after purchasing an additional 547 shares during the period. Comerica Bank lifted its stake in shares of Steris by 0.9% in the fourth quarter. Comerica Bank now owns 68,219 shares of the medical equipment provider’s stock valued at $6,255,000 after purchasing an additional 628 shares during the period. Crossmark Global Holdings Inc. lifted its stake in shares of Steris by 6.9% in the fourth quarter. Crossmark Global Holdings Inc. now owns 9,810 shares of the medical equipment provider’s stock valued at $858,000 after purchasing an additional 630 shares during the period. Ladenburg Thalmann Financial Services Inc. lifted its stake in shares of Steris by 13.3% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 5,556 shares of the medical equipment provider’s stock valued at $485,000 after purchasing an additional 652 shares during the period. Finally, OppenheimerFunds Inc. lifted its stake in shares of Steris by 9.2% in the fourth quarter. OppenheimerFunds Inc. now owns 8,352 shares of the medical equipment provider’s stock valued at $731,000 after purchasing an additional 703 shares during the period. Hedge funds and other institutional investors own 88.41% of the company’s stock.
Several brokerages have recently weighed in on STE. Zacks Investment Research downgraded shares of Steris from a “buy” rating to a “hold” rating in a report on Wednesday, January 24th. Raymond James Financial reaffirmed a “market perform” rating and issued a $100.00 target price on shares of Steris in a report on Wednesday, January 3rd. KeyCorp reaffirmed a “buy” rating and issued a $103.00 target price on shares of Steris in a report on Thursday, February 8th. Finally, Northcoast Research set a $102.00 target price on shares of Steris and gave the company a “buy” rating in a report on Thursday, February 8th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $84.80.
WARNING: “Steris PLC (STE) Director Sells $5,364,723.00 in Stock” was first published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another website, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The correct version of this report can be accessed at https://www.tickerreport.com/banking-finance/3252499/steris-plc-ste-director-sells-5364723-00-in-stock.html.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.